{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:18:35Z","timestamp":1787023115476,"version":"build-2736575974"},"reference-count":39,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1590\/abd1806-4841.20164476","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T18:53:05Z","timestamp":1462992785000},"page":"160-166","source":"Crossref","is-referenced-by-count":19,"title":["Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris"],"prefix":"10.1590","volume":"91","author":[{"given":"George","family":"Kontochristopoulos","sequence":"first","affiliation":[{"name":"\u201cAndreas Sygros\u201d Skin Hospital, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anargyros","family":"Kouris","sequence":"additional","affiliation":[{"name":"\u201cAndreas Sygros\u201d Skin Hospital, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Chantzaras","sequence":"additional","affiliation":[{"name":"University of Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Petridis","sequence":"additional","affiliation":[{"name":"\u201cAndreas Sygros\u201d Skin Hospital, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yfantopoulos","sequence":"additional","affiliation":[{"name":"University of Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl M","year":"2003","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi R","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1468-3083.2008.02692.x","article-title":"Lifetime prevalence fluctuations of chronic plaque psoriasis and other non-pustular clinical variants","volume":"22","author":"Kyriakis KP","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1468-3083.2011.04000.x","article-title":"Skin pain and skin discomfort is associated with quality of life in patients with psoriasis","volume":"26","author":"Ljosaa TM","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2340\/00015555-0851","article-title":"Pruritus is an important factor negatively influencing the well-being of psoriatic patients","volume":"90","author":"Reich A","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","article-title":"The effect of severe psoriasis on the quality of life of 369 patients","volume":"132","author":"Finlay AY","year":"1995","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-4362.1995.tb04656.x","article-title":"Age and gender differences in the impact of psoriasis on quality of life","volume":"34","author":"Gupta MA","year":"1995","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D30073R324","article-title":"Sleep disturbances in psoriasis","volume":"19","author":"Shutty BG","year":"2013","journal-title":"Dermatol Online J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2165\/00019053-199610060-00010","article-title":"The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis","volume":"10","author":"Nichol MB","year":"1996","journal-title":"Pharmacoeconomics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1468-3083.2000.00085.x","article-title":"The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients","volume":"14","author":"Devrimci-Ozguven H","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4103\/0378-6323.45101","article-title":"Quality of life in psoriasis: a study from south India","volume":"74","author":"Rakhesh SV","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1365-2133.2012.11147.x","article-title":"Evaluation of the impact of writing exercises interventions on quality of life in patients with psoriasis undergoing systemic treatments","volume":"167","author":"Tabolli S","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mjd.2003.130","article-title":"Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis","volume":"48","author":"Papp KA","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"ref14","first-page":"609","article-title":"Consensus on the use of the fixed combination calcipotriol\/betamethasone dipropionate in the treatment of plaque psoriasis","volume":"147","author":"Girolomoni G1 Vena GA","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.2008.08686.x","article-title":"Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study","volume":"159","author":"Rigopoulos D","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000334482","article-title":"Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study","volume":"223","author":"Rigopoulos D","year":"2011","journal-title":"Dermatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1468-3083.2010.03801.x","article-title":"Psoriasis in children: a retrospective analysis","volume":"25","author":"Stefanaki C","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1684\/ejd.2010.0869","article-title":"Characteristics of psoriasis in Greece: an epidemiological study of a population in a sunny Mediterranean climate","volume":"20","author":"Rigopoulos D","year":"2010","journal-title":"Eur J Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","article-title":"Adherence to topical treatment in psoriasis: a systematic literature review","volume":"26","author":"Devaux S","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2133.2010.09916.x","article-title":"Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support","volume":"163","author":"Ersser SJ","year":"2010","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jval.2013.10.003","article-title":"Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK","volume":"16","author":"Swinburn P","year":"2013","journal-title":"Value Health"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12955-014-0203-3","article-title":"Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients","volume":"13","author":"Pattanaphesaj J","year":"2015","journal-title":"Health Qual Life Outcomes"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaad.2005.10.008","article-title":"Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective","volume":"54","author":"Mease PJ","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use","volume":"19","author":"Finlay AY","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment","volume":"51","author":"Langley RG","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2133.2004.06134.x","article-title":"The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet\/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial","volume":"151","author":"Van de Kerkhof PC","year":"2004","journal-title":"Br J Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1468-3083.2009.03221.x","article-title":"Quality of life in patients with scalp psoriasis treated with calcipotriol\/betamethasone dipropionate scalp formulation: a randomized controlled trial","volume":"23","author":"Ortonne JP","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ddg.12029","article-title":"Practicability of combined treatment with calcipotriol\/betamethasone gel (Daivobet(R) Gel) and improvement of quality of life in patients with psoriasis","volume":"11","author":"Sticherling M","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-4-71","article-title":"The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study","volume":"4","author":"Shikiar R","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000130425","article-title":"Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study","volume":"217","author":"Buckley C","year":"2008","journal-title":"Dermatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2008.08927.x","article-title":"A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial","volume":"160","author":"van de Kerkhof PC","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2165\/11207300-000000000-00000","article-title":"Calcipotriolbetamethasone dipropionate: A review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp","volume":"71","author":"McCormack PL","year":"2011","journal-title":"Drugs"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00015550252948194","article-title":"A new calcipotriol\/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris","volume":"82","author":"Douglas WS","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1684\/ejd.2009.0767","article-title":"The DESIRE study - Psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice","volume":"19","author":"Clar\u00e9us BW","year":"2009","journal-title":"Eur J Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2004.06174.x","article-title":"Better medication adherence results in greater improvement in severity of psoriasis","volume":"151","author":"Carroll CL","year":"2004","journal-title":"Br J Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1365-2133.2007.07754.x","article-title":"Single application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sites","volume":"156","author":"Ulff E","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/00015555-0073","article-title":"To follow or not to follow dermatological treatment--a review of the literature","volume":"86","author":"Serup J1","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/09546634.2013.800182","article-title":"Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol(R) gel) in the treatment of scalp psoriasis: results from a study in 885 patients","volume":"25","author":"Saraceno R","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CEOR.S35046","article-title":"Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation","volume":"4","author":"Colombo GL","year":"2012","journal-title":"Clinicoecon Outcomes Res"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v91n2\/0365-0596-abd-91-02-0160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:00:43Z","timestamp":1747652443000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962016000200160&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0365-05962016000200160"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20164476","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}